Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study.

Paksoy, Nail; Khanmammadov, Nijat; Dogan, Izzet; Ferhatoglu, Ferhat; Ahmed, Melin Aydan; Karaman, Sule; Aydiner, Adnan

Paksoy, Nail; Khanmammadov, Nijat; Dogan, Izzet; Ferhatoglu, Ferhat; Ahmed, Melin Aydan; Karaman, Sule; Aydiner, Adnan.

Afiliação

Paksoy N; Department of Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey.
Khanmammadov N; Department of Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey.
Dogan I; Department of Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey.
Ferhatoglu F; Department of Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey.
Ahmed MA; Department of Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey.
Karaman S; Department of Radiation Oncology, Istanbul University Faculty of Medicine, Istanbul, Turkey.
Aydiner A; Department of Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey.

Medicine (Baltimore) ; 102(5): e32866, 2023 Feb 03.

Article em En | MEDLINE | ID: mdl-36749246

Assuntos

Sarcoma de Kaposi; Neoplasias Cutâneas; Humanos; Masculino; Adulto; Pessoa de Meia-Idade; Idoso; Idoso de 80 Anos ou mais; Paclitaxel/uso terapêutico; Sarcoma de Kaposi/complicações; Estudos Retrospectivos; Estudos Transversais; Neoplasias Cutâneas/tratamento farmacológico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma de Kaposi / Neoplasias Cutâneas Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google